112 related articles for article (PubMed ID: 38696350)
21. MicroRNA Signatures for Pancreatic Cancer and Chronic Pancreatitis: Expression Profiling by NGS.
Singh N; Khan IA; Rashid S; Rashid S; Roy S; Kaushik K; Kumar A; Das P; Lalwani S; Gupta D; Gunjan D; Dash NR; Chauhan SS; Gupta S; Saraya A
Pancreas; 2024 Mar; 53(3):e260-e267. PubMed ID: 38345909
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
[TBL] [Abstract][Full Text] [Related]
23. Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas.
Terada T; Nakanuma Y
Am J Clin Pathol; 1996 May; 105(5):613-20. PubMed ID: 8623771
[TBL] [Abstract][Full Text] [Related]
24. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
[TBL] [Abstract][Full Text] [Related]
25. Human fetal ductal plate revisited: II. MUC1, MUC5AC, and MUC6 are expressed in human fetal ductal plate and MUC1 is expressed also in remodeling ductal plate, remodeled ductal plate and mature bile ducts of human fetal livers.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):571-85. PubMed ID: 23573304
[TBL] [Abstract][Full Text] [Related]
26. Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma.
Oflas D; Canaz F; Özer İ; Demir L; Çolak E
Turk J Gastroenterol; 2023 Oct; 34(10):1014-1024. PubMed ID: 37787719
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer.
Yang JY; Sun YW; Liu DJ; Zhang JF; Li J; Hua R
Am J Cancer Res; 2014; 4(6):663-73. PubMed ID: 25520858
[TBL] [Abstract][Full Text] [Related]
28. Serum cytokine profiles in patients with pancreatic cancer and chronic pancreatitis.
Lanki M; Mustonen H; Salmi M; Jalkanen S; Haglund C; Seppänen H
Pancreatology; 2023 Sep; 23(6):657-662. PubMed ID: 37468364
[TBL] [Abstract][Full Text] [Related]
29. Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma.
Huang Y; Ren GP; Xu C; Dong SF; Wang Y; Gan Y; Zhu L; Feng TY
BMC Cancer; 2014 Jul; 14():479. PubMed ID: 24989027
[TBL] [Abstract][Full Text] [Related]
30. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.
Barrera LN; Evans A; Lane B; Brumskill S; Oldfield FE; Campbell F; Andrews T; Lu Z; Perez-Mancera PA; Liloglou T; Ashworth M; Jalali M; Dawson R; Nunes Q; Phillips PA; Timms JF; Halloran C; Greenhalf W; Neoptolemos JP; Costello E
Cancer Res; 2020 Jul; 80(13):2861-2873. PubMed ID: 32393661
[TBL] [Abstract][Full Text] [Related]
31. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
[TBL] [Abstract][Full Text] [Related]
32. Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma.
Bianchini M; Giambelluca MA; Scavuzzo MC; Di Franco G; Guadagni S; Palmeri M; Furbetta N; Gianardi D; Funel N; Ricci C; Gaeta R; Pollina LE; Falcone A; Vivaldi C; Di Candio G; Biagioni F; Busceti CL; Morelli L; Fornai F
World J Gastroenterol; 2021 Nov; 27(42):7324-7339. PubMed ID: 34876792
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
Sun B; Liu X; Gao Y; Li L; Dong Z
Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
[TBL] [Abstract][Full Text] [Related]
34. Malignancy in chronic pancreatitis: analysis of diagnostic procedures and proposal of a clinical algorithm.
Rückert F; Brussig T; Kuhn M; Kersting S; Bunk A; Hunger M; Saeger HD; Niedergethmann M; Post S; Grützmann R
Pancreatology; 2013; 13(3):243-9. PubMed ID: 23719595
[TBL] [Abstract][Full Text] [Related]
35. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
36. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
37. Expression of mucin (MUC) genes in mucoepidermoid carcinoma.
Shemirani N; Osipov V; Kolker A; Khampang P; Kerschner JE
Laryngoscope; 2011 Jan; 121(1):167-70. PubMed ID: 21072847
[TBL] [Abstract][Full Text] [Related]
38. Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis.
Guz M; Jeleniewicz W; Cybulski M; Kozicka J; Kurzepa J; Mądro A
Biomed Rep; 2021 Jan; 14(1):10. PubMed ID: 33235725
[TBL] [Abstract][Full Text] [Related]
39. A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients.
Saha G; Singh R; Mandal A; Das S; Chattopadhyay E; Panja P; Roy P; DeSarkar N; Gulati S; Ghatak S; Ghosh S; Banerjee S; Roy B; Ghosh S; Chaudhuri D; Arora N; Biswas NK; Sikdar N
Mol Med; 2020 Jun; 26(1):59. PubMed ID: 32552660
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A
Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]